West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H

被引:193
作者
Chung, Kyung Min
Liszewski, M. Kathryn
Nybakken, Grant
Davis, Alan E.
Townsend, R. Reid
Fremont, Daved H.
Atkinson, John P.
Diamond, Michael S. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA
关键词
flavivirus; immune evasion; innate immunity; pathogenesis;
D O I
10.1073/pnas.0605668103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The complement system, by virtue of its dual effector and priming functions, is a major host defense against pathogens. Flavivirus nonstructural protein (NS)-1 has been speculated to have immune evasion activity, because it is a secreted glycoprotein, binds back to cell surfaces, and accumulates to high levels in the serum of infected patients. Herein, we demonstrate an immunomodulatory function of West Nile virus NS1. Soluble and cell-surface-associated NS1 binds to and recruits the complement regulatory protein factor H, resulting in decreased complement activation in solution and attenuated deposition of C3 fragments and C5b-9 membrane attack complexes on cell surfaces. Accordingly, extracellular NS1 may function to minimize immune system targeting of West Nile virus by decreasing complement recognition of infected cells.
引用
收藏
页码:19111 / 19116
页数:6
相关论文
共 55 条
[41]   Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus [J].
Oliphant, T ;
Engle, M ;
Nybakken, GE ;
Doane, C ;
Johnson, S ;
Huang, L ;
Gorlatov, S ;
Mehlhop, E ;
Marri, A ;
Chung, KM ;
Ebel, GD ;
Kramer, LD ;
Fremont, DH ;
Diamond, MS .
NATURE MEDICINE, 2005, 11 (05) :522-530
[42]   HUMAN COMPLEMENT C3B INACTIVATOR - ISOLATION, CHARACTERIZATION, AND DEMONSTRATION OF AN ABSOLUTE REQUIREMENT FOR SERUM-PROTEIN BETA-1H FOR CLEAVAGE OF C3B AND C4B IN SOLUTION [J].
PANGBURN, MK ;
SCHREIBER, RD ;
MULLEREBERHARD, HJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (01) :257-270
[43]  
RAI J, 1977, INDIAN J MED RES, V65, P167
[44]   Binding of complement factor H to loop 5 of porin protein 1A:: A molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae [J].
Ram, S ;
McQuillen, DP ;
Gulati, S ;
Elkins, C ;
Pangburn, MK ;
Rice, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (04) :671-680
[45]   ROLE OF VIRION-ASSOCIATED GLYCOSYLPHOSPHATIDYLINOSITOL-LINKED PROTEINS CD55 AND CD59 IN COMPLEMENT RESISTANCE OF CELL LINE-DERIVED AND PRIMARY ISOLATES OF HIV-L [J].
SAIFUDDIN, M ;
PARKER, CJ ;
PEEPLES, ME ;
GORNY, MK ;
ZOLLAPAZNER, S ;
GHASSEMI, M ;
ROONEY, IA ;
ATKINSON, JP ;
SPEAR, GT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (02) :501-509
[46]   Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis [J].
Takefman, DM ;
Sullivan, BL ;
Sha, BE ;
Spear, GT .
VIROLOGY, 1998, 246 (02) :370-378
[47]   Cutting edge: Myeloid complement C3 enhances the humoral response to peripheral viral infection [J].
Verschoor, A ;
Brockman, MA ;
Knipe, DM ;
Carroll, MC .
JOURNAL OF IMMUNOLOGY, 2001, 167 (05) :2446-2451
[48]  
Volanakis JE, 2002, CURR TOP MICROBIOL, V266, P41
[49]   Advances in immunology: Complement (First of two parts). [J].
Walport, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1058-1066
[50]   Advances in immunology: Complement (Second of two parts). [J].
Walport, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (15) :1140-1144